Founded in 2008

Acquired by i-SENS in 2016

PT2 cleared by FDA in 2019

  • PT1 Developed, 2008
  • FDA Clearance, 2009
  • CLIA Waiver Granted, 2010
  • ISO 13485 Granted, 2011
  • PT2 Developed, 2017

Our Mission:

Enable people with coagulation disorders to live a healthier life

Our Vision:

Empower our patients with actionable information at point of care